Is Aktis Oncology, Inc. (AKTS) a Buy, Sell, or Hold?
NASDAQ : AKTS
Aktis Oncology, Inc. — Analyst Ratings
$23.89 USD
-$0.12 (-0.5%)
- Volume
- 193.8K
- Average Volume
- 344.8K
- Market Capitalization
- $1.28B
- P/E Ratio
- -39.16
- Dividend Yield
- 0.00%
- Price Target
- $35.00
- Year High
- $34.19
- Year Low
- $14.72
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $19.49
Analyst Consensus Summary
Consensus Rating
Sell
8 Analysts
Rating Score
2/5
Recommendation Strength
Upside/Downside
-31.7%
vs Current Price
Price Target
$35.00
Average TargetPrice Target Range
Lowest Target
$31.00
-22.9% DOWNSIDE
Average Target
$35.00
Median Estimate
Highest Target
$40.00
-40.3% DOWNSIDEAnalyst Breakdown
Overall Consensus: Buy | Total Analysts: 8
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 0 | 5 | 3 | 0 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Raymond James | Christopher Raymond | $40 | $20.69 | 2026-06-15 04:07 PM | 93.3% |
| H.C. Wainwright | Robert Burns | $35 | $19.61 | 2026-06-02 11:44 AM | 78.5% |